Clinical Trial Update: Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

View source ↗

Summary

A real-world study evaluating teplizumab in patients with Type 1 diabetes mellitus under managed access programs is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• TZIELD (TEPLIZUMAB-MZWV)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes | Status: RECRUITING